Cholesterol, high-density lipoprotein, and glucose index as a cardiometabolic marker associated with heart rate variability and 1-year cardiovascular rehospitalization in chronic coronary syndromes with comorbid anxiety: a retrospective cohort study - Summary - MDSpire

Cholesterol, high-density lipoprotein, and glucose index as a cardiometabolic marker associated with heart rate variability and 1-year cardiovascular rehospitalization in chronic coronary syndromes with comorbid anxiety: a retrospective cohort study

  • By

  • Yuan Gao

  • Yiwei Xu

  • Chuxin Lyu

  • Yuhan Ding

  • Siyuan Yin

  • Ruijie Shi

  • Jiemei Zhou

  • Haowen Zhang

  • Xiaohu Chen

  • June 18, 2026

  • 0 min

Share

Objective:

To investigate the associations of the cholesterol, high-density lipoprotein, and glucose (CHG) index with heart rate variability (HRV) and 1-year cardiovascular rehospitalization in patients with chronic coronary syndromes (CCS) and comorbid anxiety, highlighting the significance of these associations in improving patient outcomes.

Key Findings:
  • Patients in the highest CHG quartile (Q4) had significantly lower HRV_z compared to those in the lowest quartile (Q1) (β = -0.529, P < 0.001).
  • Each 1-unit increase in CHG was associated with a higher risk of 1-year cardiovascular rehospitalization (OR = 3.253, P < 0.001).
  • Patients in Q4 had a higher rehospitalization risk than those in Q1 (OR = 3.656, P < 0.001).
  • Higher HRV_z was associated with lower rehospitalization risk in exploratory analyses, with 'HRV_z' defined earlier in the summary.
Interpretation:

Elevated CHG is associated with increased 1-year cardiovascular rehospitalization risk in patients with CCS and comorbid anxiety, with lower HRV_z linked to higher rehospitalization risk, emphasizing the implications for clinical practice.

Limitations:
  • The study's retrospective design limits causal inferences and may introduce biases.
  • Standardized anxiety scale scores and treatment adherence data were not available for stratified analyses, which could affect the robustness of the findings.
Conclusion:

CHG and Holter-derived HRV_z may provide complementary information for risk assessment in patients with CCS and comorbid anxiety, suggesting potential clinical applications for improving patient management.

Original Source(s)

Related Content